Takeda Pharmaceutical Company Limited
TAK · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $681,486 | $350,008 | $385,113 | $494,126 |
| Short-Term Investments | $58,192 | $69,167 | $20,476 | $32,621 |
| Receivables | $702,238 | $679,531 | $725,254 | $735,064 |
| Inventory | $1,299,486 | $1,240,676 | $1,217,349 | $1,246,427 |
| Other Curr. Assets | $179,218 | $173,740 | $173,000 | $246,049 |
| Total Curr. Assets | $2,920,620 | $2,513,122 | $2,521,192 | $2,754,287 |
| Property Plant & Equip (Net) | $1,984,126 | $1,956,269 | $1,968,209 | $2,017,776 |
| Goodwill | $5,431,698 | $5,295,871 | $5,324,430 | $5,522,112 |
| Intangibles | $3,299,225 | $3,422,542 | $3,631,560 | $3,952,039 |
| Long-Term Investments | $374,332 | $347,120 | $361,926 | $410,206 |
| Tax Assets | $389,768 | $401,058 | $370,745 | $376,264 |
| Other NC Assets | $70,531 | $68,555 | $70,282 | $74,158 |
| Total NC Assets | $11,549,680 | $11,491,415 | $11,727,152 | $12,352,555 |
| Other Assets | $0 | $0 | $0 | $2 |
| Total Assets | $14,470,300 | $14,004,537 | $14,248,344 | $15,106,844 |
| Liabilities | – | – | – | – |
| Payables | $438,985 | $421,308 | $308,450 | $460,181 |
| Short-Term Debt | $293,858 | $371,143 | $548,939 | $135,467 |
| Tax Payable | $122,907 | $150,965 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,283,905 | $1,226,170 | $1,649,132 | $1,502,316 |
| Total Curr. Liab. | $2,139,655 | $2,169,586 | $2,506,521 | $2,097,964 |
| LT Debt | $4,351,462 | $4,134,799 | $3,966,326 | $4,704,681 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $33,029 | $33,514 | $35,153 | $37,670 |
| Other NC Liab. | $814,465 | $800,458 | $804,365 | $847,338 |
| Total NC Liab. | $5,198,956 | $4,968,771 | $4,805,844 | $5,589,689 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7,338,611 | $7,138,357 | $7,312,365 | $7,687,653 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,694,759 | $1,694,711 | $1,694,685 | $1,694,660 |
| Retained Earnings | $1,148,658 | $1,156,692 | $1,187,586 | $1,290,948 |
| AOCI | -$3,595 | $2,347,471 | $2,351,915 | $2,701,502 |
| Other Equity | $4,290,875 | $1,666,385 | $1,700,898 | $1,731,164 |
| Total Equity | $7,130,697 | $6,865,259 | $6,935,084 | $7,418,274 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $992 | $921 | $895 | $917 |
| Total Liab. & Tot. Equity | $14,470,300 | $14,004,537 | $14,248,344 | $15,106,844 |
| Net Debt | $3,963,834 | $4,155,934 | $4,130,152 | $4,346,022 |